1. Home
  2. AUTL vs DOMO Comparison

AUTL vs DOMO Comparison

Compare AUTL & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUTL
  • DOMO
  • Stock Information
  • Founded
  • AUTL 2014
  • DOMO 2010
  • Country
  • AUTL United Kingdom
  • DOMO United States
  • Employees
  • AUTL N/A
  • DOMO N/A
  • Industry
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • AUTL Health Care
  • DOMO Technology
  • Exchange
  • AUTL Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • AUTL 625.4M
  • DOMO 562.5M
  • IPO Year
  • AUTL 2018
  • DOMO 2018
  • Fundamental
  • Price
  • AUTL $1.38
  • DOMO $16.85
  • Analyst Decision
  • AUTL Strong Buy
  • DOMO Buy
  • Analyst Count
  • AUTL 5
  • DOMO 8
  • Target Price
  • AUTL $9.12
  • DOMO $15.13
  • AVG Volume (30 Days)
  • AUTL 4.4M
  • DOMO 867.4K
  • Earning Date
  • AUTL 11-11-2025
  • DOMO 08-27-2025
  • Dividend Yield
  • AUTL N/A
  • DOMO N/A
  • EPS Growth
  • AUTL N/A
  • DOMO N/A
  • EPS
  • AUTL N/A
  • DOMO N/A
  • Revenue
  • AUTL $29,934,000.00
  • DOMO $318,363,000.00
  • Revenue This Year
  • AUTL $634.25
  • DOMO $1.78
  • Revenue Next Year
  • AUTL $93.16
  • DOMO $2.66
  • P/E Ratio
  • AUTL N/A
  • DOMO N/A
  • Revenue Growth
  • AUTL 185.17
  • DOMO N/A
  • 52 Week Low
  • AUTL $1.11
  • DOMO $6.01
  • 52 Week High
  • AUTL $5.00
  • DOMO $17.88
  • Technical
  • Relative Strength Index (RSI)
  • AUTL 28.28
  • DOMO 61.46
  • Support Level
  • AUTL $1.34
  • DOMO $13.85
  • Resistance Level
  • AUTL $1.46
  • DOMO $17.88
  • Average True Range (ATR)
  • AUTL 0.09
  • DOMO 0.89
  • MACD
  • AUTL 0.01
  • DOMO 0.22
  • Stochastic Oscillator
  • AUTL 9.09
  • DOMO 74.07

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: